Intensive Transition Support for Chronic Illness
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Intensive Transition Support for Children and Youth with Medical Complexity?
Research shows that coordinated models of care can improve health outcomes for children with medical complexity during transitions. Additionally, a core outcome set for transitional care includes important factors like disease management and quality of life, which are essential for evaluating the effectiveness of such interventions.12345
Is Intensive Transition Support for Chronic Illness safe for humans?
The research highlights that children with medical complexity face risks during transitions in care, but coordinated care models can improve outcomes. Families of these children can identify safety gaps, suggesting that while there are safety concerns, improvements are possible with better care coordination.16789
How is the Intensive Transition Support treatment different from other treatments for children with medical complexity?
Intensive Transition Support is unique because it focuses on providing coordinated care during the transition from pediatric to adult healthcare, addressing both the medical and emotional needs of children with medical complexity and their families. This approach involves a multidisciplinary team to ensure a smooth transition and improve health outcomes, which is not typically emphasized in standard treatments.110111213
What is the purpose of this trial?
This is a mixed-methods evaluative study examining the effectiveness of the Transition to Adult Care Program at the Hospital for Sick Children (TAC) Program on high-risk youth with medical and psychosocial complexity transitioning to adult and/or primary care services.The overarching aim is to study the effectiveness of a new interdisciplinary and holistic Transition to Adult Care Program (TAC) on health-related outcomes for high-risk youth with multimorbidity or rare diseases and their caregivers by:1. Assess the effect of the TAC program on the youth's transition readiness, self-efficacy, self-management, health-related quality of life, and satisfaction.2. Assess the effect of the TAC program on the caregiver's satisfaction.3. Explore the experiences, perceptions, needs, and priorities of youth and caregivers participating in the TAC program using qualitative research methods.4. Describe the feasibility of the TAC program (defined as success in patient recruitment, attendance, participation, retention and transfer).
Eligibility Criteria
The TAC Program trial is for high-risk youth with multiple chronic physical and/or mental health conditions, or a rare disease/genetic condition. Participants must lack an identified adult care provider post-transfer or face significant social and structural health barriers.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Transition Intervention
Participants co-create an individualized transition plan and receive a patient-specific transfer package
Introduction to Adult Services
A joint clinic visit facilitated by the transition team with the identified receiving adult care provider
Follow-up
Participants are monitored for satisfaction and quality of life improvements after transition
Treatment Details
Interventions
- Intensive Transition Support
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Hospital for Sick Children
Lead Sponsor